[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Chu, 2022 - Google Patents

Protein Degradation Pathways Associated with Nonsense-Mediated mRNA Decay

Chu, 2022

View PDF
Document ID
6835419512741123269
Author
Chu V
Publication year

External Links

Snippet

The presence of a premature termination codon (PTC) in an mRNA results in the generation of a truncated protein which may aggregate or perform dominant negative functions in the cell. To limit the production of these truncated proteins and their deleterious effects, PTC …
Continue reading at dash.harvard.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Similar Documents

Publication Publication Date Title
Kearse et al. Non-AUG translation: a new start for protein synthesis in eukaryotes
Jung et al. Multiplex image-based autophagy RNAi screening identifies SMCR8 as ULK1 kinase activity and gene expression regulator
Kervestin et al. NMD: a multifaceted response to premature translational termination
Valentin-Vega et al. Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation
Dantuma et al. The ubiquitin receptor Rad23: at the crossroads of nucleotide excision repair and proteasomal degradation
Keam et al. The human Piwi protein Hiwi2 associates with tRNA-derived piRNAs in somatic cells
WO2020077135A1 (en) Modulating resistance to bcl-2 inhibitors
Hollensen et al. circZNF827 nucleates a transcription inhibitory complex to balance neuronal differentiation
De et al. A comprehensive coverage insurance for cells: revealing links between ribosome collisions, stress responses and mRNA surveillance
Iwamoto et al. Transcription-dependent nucleolar cap localization and possible nuclear function of DExH RNA helicase RHAU
Krshnan et al. Regulated degradation of the inner nuclear membrane protein SUN2 maintains nuclear envelope architecture and function
AU2015330730A1 (en) Plasmids comprising internal ribosomal entry sites and uses thereof
Li et al. USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1
Li et al. USP28 regulates deubiquitination of histone H2A and cell proliferation
Chu et al. Selective destabilization of polypeptides synthesized from NMD-targeted transcripts
Zhou et al. TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1
Eisenack et al. Ending a bad start: Triggers and mechanisms of co-translational protein degradation
Chu Protein Degradation Pathways Associated with Nonsense-Mediated mRNA Decay
Gan et al. USP16 is an ISG15 cross-reactive deubiquitinase targeting a subset of metabolic pathway-related proteins
Shah Unravelling the Molecular Mechanism of Unkempt-Induced Cell Morphogenesis
Blears et al. Redundant pathways for removal of defective RNA polymerase II complexes at a promoter-proximal pause checkpoint
Ng Characterizing the Human Ubiquitin Conjugating Enzymes
Yi Roles of Mammalian UPF3 Paralogs in Nonsense-mediated mRNA Decay Pathway
Sun et al. MCM7 Ubiquitination Regulates CMG Helicase Disassembly in Human
Mackay et al. USP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication.